Ming Su
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Esophageal Cancer Research and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal and GI Pathology
Papers in
- Surgery 14
- Esophageal Cancer Research and Treatment 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Esophageal and GI Pathology 3
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Shaokang Wang (17 shared papers)Guiju Sun (18 shared papers)Da Pan (13 shared papers)Xiao Qin (1 shared paper)Bin Chen (1 shared paper)Ting Zhang (3 shared papers)Kai Jiang (4 shared papers)Zhiqiang Huang (4 shared papers)
- Journals
- Nutrients (3 papers)European Journal of Cancer Prevention (2 papers)European Journal of Surgical Oncology (2 papers)Toxins (1 paper)Frontiers in Public Health (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Ming Su
30 papers receiving 330 citations
Peers
Comparison fields: 5 of 62
- Hepatology 31
- Surgery 143
- Rheumatology 29
- Pulmonary and Respiratory Medicine 57
- Cancer Research 24
Countries citing papers authored by Ming Su
This map shows the geographic impact of Ming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Su more than expected).
Fields of papers citing papers by Ming Su
This network shows the impact of papers produced by Ming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Su. The network helps show where Ming Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 64 | |
| 2 | 2016 | 41 | |
| 3 | 2019 | 26 | |
| 4 | 2013 | 21 | |
| 5 | 2019 | 18 | |
| 6 | 2019 | 16 | |
| 7 | 2020 | 14 | |
| 8 | 2018 | 13 | |
| 9 | 2013 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2019 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2014 | 9 | |
| 16 | 2013 | 8 | |
| 17 | 2021 | 6 | |
| 18 | 2025 | 6 | |
| 19 | A case-control study on the risk factors for esophageal cancer. | 2009 | 4 |
| 20 | 2022 | 4 |
About Ming Su
Ming Su is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Rheumatology, Hepatology and Molecular Biology, having authored 30 papers that have together received 332 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), Folate and B Vitamins Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Nutritional Studies and Diet (3 papers), Esophageal and GI Pathology (3 papers), Cancer Risks and Factors (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hepatology (31 citations), Surgery (143 citations), Rheumatology (29 citations), Pulmonary and Respiratory Medicine (57 citations) and Cancer Research (24 citations). Ming Su has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shaokang Wang, Guiju Sun, Da Pan, Xiao Qin, Bin Chen, Ting Zhang, Kai Jiang, Zhiqiang Huang, Tao Peng and Kaiyin Xiao. Their work appears in journals such as Nutrients, European Journal of Cancer Prevention, European Journal of Surgical Oncology, Toxins and Frontiers in Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.